190 related articles for article (PubMed ID: 20198556)
21. Postmenopausal mild hirsutism and hyperandrogenemia due to granulosa cell tumor of the ovary: a case report.
Adefris M; Fekadu E
J Med Case Rep; 2017 Aug; 11(1):242. PubMed ID: 28851436
[TBL] [Abstract][Full Text] [Related]
22. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
[TBL] [Abstract][Full Text] [Related]
23. Hilus cell pathology and hirsutism.
McLellan AR; Mowat A; Cordiner J; Beastall GH; Wallace AM; Connell JM; Davies DL
Clin Endocrinol (Oxf); 1990 Feb; 32(2):203-12. PubMed ID: 2112066
[TBL] [Abstract][Full Text] [Related]
24. Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases.
Hofland M; Cosyns S; De Sutter P; Bourgain C; Velkeniers B
Gynecol Endocrinol; 2013 Mar; 29(3):213-5. PubMed ID: 22835278
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of selective venous catheterization in localizing a small androgen-producing tumor in ovary.
Nishiyama S; Hirota Y; Udagawa Y; Kato R; Hayakawa N; Tukada K
Med Sci Monit; 2008 Feb; 14(2):CS9-12. PubMed ID: 18227769
[TBL] [Abstract][Full Text] [Related]
26. Laparoscopic removal of virilizing hilar cell tumor in a postmenopausal patient.
Silva PD; Sorensen ML; Reynertson R; Virata RL; Mahairas GH
J Am Assoc Gynecol Laparosc; 1997 Aug; 4(4):499-502. PubMed ID: 9224588
[TBL] [Abstract][Full Text] [Related]
27. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
Cserepes E; Szücs N; Patkós P; Csapó Z; Molnár F; Tóth M; Dabasi G; Esik O; Rácz K
Gynecol Endocrinol; 2002 Jun; 16(3):213-6. PubMed ID: 12192893
[TBL] [Abstract][Full Text] [Related]
28. Alopecia and hirsutism in a postmenopausal woman as the presenting complaint of ovarian hilus (Leydig) cell tumor.
Berbegal L; Albares MP; De-Leon FJ; Negueruela G
Actas Dermosifiliogr; 2015 Oct; 106(8):676-8. PubMed ID: 25910403
[No Abstract] [Full Text] [Related]
29. [Endocrine profile and electron microscopic study of ovarian androblastoma].
Inoue S; Fukuda O; Koyama N; Furuki Y; Munemura M; Maeyama M; Mizumoto J; Miyayama Y
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Aug; 36(8):1155-62. PubMed ID: 6096462
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis and resection of an oral contraceptive-suppressible Sertoli-Leydig cell tumor with preservation of fertility and a 7-year follow-up.
Haning RV; Loughlin J; Shapiro SS
Obstet Gynecol; 1989 May; 73(5 Pt 2):901-5. PubMed ID: 2523030
[TBL] [Abstract][Full Text] [Related]
31. Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation.
Ferrinho C; Silva E; Oliveira M; Sequeira Duarte J
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33731391
[TBL] [Abstract][Full Text] [Related]
32. Intraoperative testosterone assay for virilizing ovarian tumor topographic assessment: report of a Leydig cell tumor of the ovary in a premenopausal woman with an adrenal incidentaloma.
Regnier C; Bennet A; Malet D; Guez T; Plantavid M; Rochaix P; Monrozies X; Louvet JP; Caron P
J Clin Endocrinol Metab; 2002 Jul; 87(7):3074-7. PubMed ID: 12107203
[TBL] [Abstract][Full Text] [Related]
33. Bilateral hilus cell tumors of the ovary.
Baramki TA; Leddy AL; Woodruff JD
Obstet Gynecol; 1983 Jul; 62(1):128-31. PubMed ID: 6856214
[TBL] [Abstract][Full Text] [Related]
34. Hyperandrogenism due to a testosterone-secreting Sertoli-Leydig cell tumor associated with a dehydroepiandrosterone sulfate-secreting adrenal adenoma in a postmenopausal woman: case presentation and review of literature.
Herrera JD; Davidson JA; Mestman JH
Endocr Pract; 2009 Mar; 15(2):149-52. PubMed ID: 19289327
[TBL] [Abstract][Full Text] [Related]
35. Pure leydig cell tumour of the ovary in a post-menopausal patient with severe hyperandrogenism and erythrocytosis.
Yetkin DO; Demirsoy ET; Kadioglu P
Gynecol Endocrinol; 2011 Apr; 27(4):237-40. PubMed ID: 20518640
[TBL] [Abstract][Full Text] [Related]
36. Ovarian Leydig cell tumor in a post-menopausal patient with severe hyperandrogenism.
Souto SB; Baptista PV; Braga DC; Carvalho D
Arq Bras Endocrinol Metabol; 2014 Feb; 58(1):68-75. PubMed ID: 24728167
[TBL] [Abstract][Full Text] [Related]
37. Sertoli-Leydig cell tumor presenting hyperestrogenism in a postmenopausal woman: a case report and review of the literature.
Guo L; Yang X; Zhu H; Qiu W; Shi X; Huang B; Duan T
Taiwan J Obstet Gynecol; 2012 Dec; 51(4):620-4. PubMed ID: 23276568
[TBL] [Abstract][Full Text] [Related]
38. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C
J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
[TBL] [Abstract][Full Text] [Related]
39. [Why aren't Leydig cell tumors of the ovary diagnosed in time?].
Vujović S; Penezić Z; Dragojlović Z; Drezgić M
Med Pregl; 2001; 54(1-2):85-8. PubMed ID: 11432330
[TBL] [Abstract][Full Text] [Related]
40. [Severe postmenopausal hyperandrogenism due to an ovarian lipoid cell tumor: a case report].
Bernasconi D; Del Monte P; Marinaro E; Marugo A; Marugo M
Minerva Endocrinol; 2004 Mar; 29(1):25-9. PubMed ID: 15258555
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
